BTA
Click for more information
0.00% 57.0¢ biota holdings limited

Not surprised that GSK abandoned IV Relenza. Their profit is...

  1. autoflight
    850 Posts.
    clock Created with Sketch.
    26/10/09
    13:11
    Post #: 5831106
    Not surprised that GSK abandoned IV Relenza. Their profit is from new vaccines every year. Better for GSK than to find a heap of generic IV Relenza look-a-like vaccine alternatives flooding their market when the patent expires in 2014. GSK cannot serve BTA when it has only one master - GSK.
    BTA Price at posting: $3.12 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.